Diabetic nephropathy urinary protein quantification of 3g suggests clinical proteinuria or massive proteinuria stage, and the treatment includes controlling blood glucose, controlling blood pressure and blood lipids, and renin-angiotensin inhibitor therapy.
Diabetic kidney disease is the most common cause of end-stage renal disease in the world, and the prevalence is still high, although the incidence has declined in recent years due to better management. Diabetic nephropathy is a complex disease with many risk factors and pathogenic factors involved. Treatment includes control of blood glucose, control of blood pressure and blood lipids, and application of renin-angiotensin inhibitor therapy.
1. Blood glucose control: commonly used drugs include metformin, acarbose, dagliflozin and so on,
2. Renin-angiotensin inhibitor treatment: including valsartan, chlorosartan, captopril, enalapril and so on.
3. Control blood pressure and blood lipid: drugs including Benadryl, Amlodipine, Atorvastatin, Pravastatin, etc..
Patients with diabetic nephropathy should go to the hospital in time and be treated under the guidance of professional physicians.